NLRP3 and familial dilated cardiomyopathy: We also focus on the underlying mechanism of the NLRP3 inflammasome in DCM and discuss several promising therapeutic strategies targeting the NLRP3 inflammasome to provide a new perspective for the prevention and treatment of DCM in the future.